IPO Biom'up

Listing of Biom'up on Euronext

Etienne Binant, Chief Executive, Biom'up, opens the trading day in Paris.

Biom'up specializes in research, development and manufacturing of implantable and resorbable collagen-based medical devices for surgery and regenerative medicine. The group especially offers haemostatic products that help control bleeding during surgery (Hemoblast) and collagen membranes that prevent organ adherence during surgery (Cova).